In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.
retrieved 10 October 2023 from https://medicalxpress.com/news/2023-10-covid-odds-immune-disorders-crohn.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Dec 16, 2022Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
I used Korean skincare products for a month and my routine will never be the sameI've reviewed the best Korean skincare products on the market to see if they live up to the hype, including the likes of LANEIGE, Innisfree, Dr Jart & Beauty of Joseon.
Read more »
South Korean regulators vow to curb ‘theme stocks’ crazeKosdaq one of world’s best performers as retail investors pile into superconductor, battery materials and salt stocks
Read more »
Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infectionsSymptom profiles between individuals with prior COVID-19 and those with other acute respiratory infections (ARIs).
Read more »
Nirmatrelvir and ritonavir combo cuts COVID-19 risks for high-vulnerability groupsitemprop=description content=Nirmatrelvir and ritonavir treatment significantly reduces the risk of hospitalization and death from COVID-19 in high-risk individuals, according to a recent JAMA Network Open study. However, the treatment's efficacy varied based on the degree of vulnerability, emphasizing tailored approaches for different risk groups.
Read more »
COVID-19's ripple effect: South African TB diagnostics take a hititemprop=description content=COVID-19 disrupts TB diagnostic services in South Africa's primary health clinics, highlighting the need for robust systems resilient to future pandemics.
Read more »